// App-Quantinova.ai

TCT-244 : Baseline Thrombocytopenia: A Strong Predictor Of One-Year Adverse Ischemic Events In Patients With ACS Undergoing PCI: A Pooled analysis From ACUITY And HORIZONS-AMI Trials

Researchers

Presenter

  • Mayank Yadav

Principal Investigators

  • Philippe Genereux

  • Ajay J. Kirtane

  • Mahesh V. Madhavan

  • Ke Xu

  • Sorin Brener

  • Roxana Mehran

  • Gregg Stone

Medical Centers

  • Mount Sinai Medical Center, New York, NY

  • Cardiovascular Research Foundation, Orangeburg, NY

  • New York Methodist Hospital, NewYork, NY

  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Renal insufficiency

  • Thrombocytopenia

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved